Effect of ampicillin on the bleeding time of neonatal intensive care unit patients

M J Sheffield1, D K Lambert, E Henry

  • 1Department of Neonatology, Intermountain Healthcare, McKay-Dee Hospital Center, Ogden, UT 84403, USA. Mark.sheffield@imail.org

Abstract

Insights

Intravenous ampicillin in neonatal intensive care unit (NICU) patients prolongs bleeding time, similar to adults. This effect is dose-dependent and takes approximately 24 hours to manifest, impacting platelet function.

Area of Science:

  • Neonatal pharmacology
  • Hematology
  • Clinical pharmacology

Background:

  • Ampicillin is commonly used in neonatal intensive care units (NICUs).
  • Adult studies show ampicillin impairs platelet function and prolongs bleeding time in a dose-dependent manner.
  • The effect on bleeding time in NICU patients has not been previously reported.

Purpose of the Study:

  • To investigate the effect of intravenous ampicillin on bleeding time in neonatal intensive care unit (NICU) patients.
  • To compare the ampicillin-induced changes in bleeding time in neonates to those observed in adults.

Main Methods:

  • Neonatal template bleeding times and Platelet Function Analyzer (PFA)-100 tests were conducted on 15 NICU patients.
  • Tests were performed before and at various intervals after intravenous ampicillin administration.
  • Patients received ampicillin at 50-100 mg/kg every 12 hours; mothers did not receive beta-lactam antibiotics during labor.

Main Results:

  • Before ampicillin, mean bleeding time was 134 seconds and mean PFA-100 time was 123 seconds.
  • Following the first ampicillin dose, no significant increase in bleeding or PFA-100 times was observed.
  • After the third and fourth doses, bleeding times increased by an average of 60 seconds (P<0.001), while PFA-100 times showed a non-significant increase.

Conclusions:

  • Intravenous ampicillin administration in NICU patients prolongs bleeding time.
  • The magnitude and time course of the effect are similar to those previously reported in adult studies.
  • Ampicillin's impact on bleeding time in neonates warrants consideration in clinical practice.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Epistaxis01:30

Epistaxis

Epistaxis, or nosebleeds, occurs when small, swollen blood vessels in the nasal mucous membrane rupture. Typically, the anterior septum is the primary site of occurrence.
Etiology
Possible causes of this condition include high blood pressure, trauma, low humidity, upper respiratory tract infections, allergies, foreign bodies, nasal inhalation of corticosteroids or illicit drugs, excessive use of decongestant nasal sprays, facial or nasal surgery, anatomic malformation, tumors, or systemic...